Guru Raghavendra Valicherla (Guru R Valicherla)

ResearcherID Loop profile Scopus Author ID Pitt ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Molecules (Basel, Switzerland)

Scientific reports

Pharmaceutics

GVK Biosciences Pvt Ltd

Central Drug Research Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GVK Biosciences Pvt Ltd Jun 14 2017

India

Scientific Manager :: DMPK Biology

Education History

Central Drug Research Institute Jul 31 2012

India

PHD :: Pharmacokinetics and Metabolism

National Institute of Pharmaceutical Education and Research Aug 02 2010 - Jul 01 2012

India

MSC :: Pharmaceutics

Publications

Shailesh D Dadge, Anees A Syed, Athar Husain, Guru Raghavendra Valicherla, Jiaur Rahaman Gayen
Simultaneous Estimation of Quercetin and trans -Resveratrol in Cissus quadrangularis Extract in Rat Serum Using Validated LC-MS/MS Method: Application to Pharmacokinetic and Stability Studies. Molecules (Basel, Switzerland) 28 (12) (2023)
Shailesh D Dadge, Anees A Syed, Athar Husain, Guru Raghavendra Valicherla, Jiaur Rahaman Gayen
Simultaneous Estimation of Quercetin and trans -Resveratrol in Cissus quadrangularis Extract in Rat Serum Using Validated LC-MS/MS Method: Application to Pharmacokinetic and Stability Studies. Molecules (Basel, Switzerland) 28 (12) (2023)
Shailesh D Dadge, Anees A Syed, Athar Husain, Guru Raghavendra Valicherla, Jiaur Rahaman Gayen
Simultaneous Estimation of Quercetin and trans -Resveratrol in Cissus quadrangularis Extract in Rat Serum Using Validated LC-MS/MS Method: Application to Pharmacokinetic and Stability Studies. Molecules (Basel, Switzerland) 28 (12) (2023)
Ruohui Zheng, Guru Raghavendra Valicherla, Junmei Zhang, Jeremy Nuttall, Peter Silvera, Leslie J Marshall, Philip E Empey, Lisa C Rohan
Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions. Pharmaceutics 14 (9) (2022)
Guru Raghavendra Valicherla, Roshan A Katekar, Shailesh Dadge, Mohammed Riyazuddin, Anees A Syed, Sandeep K Singh, Athar Husain, Muhammad Wahajuddin, Jiaur Rahaman Gayen
Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings. Molecules (Basel, Switzerland) 27 (2) (2022)
Guru Raghavendra Valicherla, Phillip Graebing, Junmei Zhang, Ruohui Zheng, Jeremy Nuttall, Peter Silvera, Lisa Cencia Rohan
Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole. Pharmaceutics 13 (12) (2021)
Zakir Hossain, Guru Raghavendra Valicherla, Anand P Gupta, Anees A Syed, Mohammed Riyazuddin, Sharat Chandra, Mohammad I Siddiqi, Jiaur Rahaman Gayen
Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus. Scientific reports 8 (1) (2018)
Mohd Kamil Hussain, Deependra Kumar Singh, Akhilesh Singh, Mohd Asad, Mohd Imran Ansari, Mohammad Shameem, Shagun Krishna, Guru Raghavendra Valicherla, Vishal Makadia, Sanjeev Meena, Amit Laxmikant Deshmukh, Jiaur R Gayen, Mohammad Imran Siddiqi, Dipak Datta, Kanchan Hajela, Dibyendu Banerjee
A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models. Scientific reports 7 (1) (2017)

Guru Raghavendra Valicherla.css-eqlu8i{font-size:small;padding-left:4px;} (Guru R Valicherla)

Publication Activity (10 Years)

Top Topics

Top Venues

Guru Raghavendra Valicherla (Guru R Valicherla)